JayY.GillenwaterMD
Urology • Charlottesville, VAAssistant Professor of Pediatrics, CF University of Virginia
Dr. Gillenwater is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2nd Hospital Dr
Charlottesville, VA 22908Phone+1 434-924-2224Fax+1 434-982-3652
Education & Training
Graduate Hospital PhiladelphiaResidency, Urology, 1962 - 1964- Graduate HospitalResidency, Internal Medicine, 1959 - 1960
- Graduate Hospital PhiladelphiaInternship, Transitional Year, 1958 - 1959
University of Tennessee Health Science Center College of MedicineClass of 1957
Certifications & Licensure
VA State Medical License 1965 - 2022
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 16 citationsElevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lup...Bahaa S. Malaeb, Thomas A. Gardner, Vitaly Margulis, Ling Yang, Jay Y. Gillenwater
Urology. 2005-10-01 - 10 citationsHigh and intermediate risk prostate cancer treated with three-dimensional computed tomography-guided brachytherapy: 2–8-year follow-upPanos Koutrouvelis, Jay Y. Gillenwater, Niko Lailas, Fred Hendricks, Stuart Katz
Radiotherapy and Oncology. 2003-06-01 - 92 citationsPhase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic horm...Hiroyuki Kubo, Thomas A. Gardner, Yoshitaka Wada, Kenneth S. Koeneman, Akinobu Gotoh
Human Gene Therapy. 2003-02-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
